This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

APOTECAchemo™ Surpasses 18 Months Of Continuous Use In The United States, Demonstrating Excellent Safety, Efficiency And Cost Control

NASHVILLE, Tenn., March 19, 2013 /PRNewswire/ -- The first two installations of Apoteca in the United States took place at the Cleveland Clinic and Wake Forest University Baptist Medical CenterCleveland Clinic's implementation plan included a lengthy review and approval by the Ohio Board of Pharmacy. Both facilities deployed Apoteca in busy oncology centers serving both inpatients and outpatients.  Daily production includes complex doses that require reconstitution, multiple vials, bags requiring final volume adjustment, and products requiring delicate handling, like monoclonal agents.

Next month, the University of Maryland Medical System will take delivery and install the next Apoteca.  The University of Maryland joins the number of worldwide pharmacies in active daily production with APOTECAchemo™, where safety, efficiency, workload relief and cost reduction are being realized in one elegant package.

Another critically important achievement at Cleveland Clinic was the activation of an HL-7 interface with Epic's healthcare information system, eliminating duplicate entry and the related risk of transcription errors.   Wake Forest will deploy a similar interface to Epic.

Production has continued to grow, reaching about 75% to 80% of daily volume, and is expected to increase further, as seen in other Apoteca installations making over 100 doses per day.  Each site chooses from nearly 60 chemical entities and 300 different vials supported by Apoteca, allowing the selection of products that provide maximum benefit.  Apoteca's flexibility has also helped protect against drug shortages by efficiently switching to alternate sources. 

Importantly, Apoteca is supported by an experienced service organization with more than 25 years of success in industrial engineering, healthcare and robotics, resulting in documented up-time percentages of 98.5% or higher.  Excellent support and product maturity also makes installation easier than one might think.  At Wake Forest , for example, installation from loading dock to making initial patient doses took fewer than 30 days.

Confidence continues to grow in Apoteca's onboard patient and staff safety features.  Apoteca includes the scientific elements of other standalone products using balances, scanners and cameras for validation and documentation.  It promotes staff safety and cost control through physical separation of humans from the compounding process, without requiring certain closed system transfer devices.  This elimination represents a cost-saving opportunity of $10.00 to $12.00 per dose.

For more information please visit:


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs